Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Hasin

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
JACC. Clinical Electrophysiology|April 25, 2024
Incidence and Predictors for Recurrence of Ventricular Arrhythmia Presenting During Acute Myocarditis: A Multicenter StudyMoshe Rav-Acha, Kushal Shah, Tal Hasin, et al.
Circulation|September 6, 2022
Myocarditis After <i>BNT162b2</i> COVID-19 Third Booster Vaccine in IsraelDror Mevorach, Emilia Anis, Noa Cedar, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 24, 2017
Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One YearTal Hasin, Avishay Grupper, John J Dillon, et al.
Transplantation|January 18, 2013
Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound studyYan Topilsky, Manish J Gandhi, Tal Hasin, et al.
JAMA Network Open|March 29, 2024
Culprit Lesion Coronary Intervention Before Complete Angiography in ST-Elevation Myocardial Infarction: A Randomized Clinical TrialNir Levi, Rafael Wolff, Rami Jubeh, et al.
Journal of the American College of Cardiology|December 24, 2011
Changes in renal function after implantation of continuous-flow left ventricular assist devicesTal Hasin, Yan Topilsky, John A Schirger, et al.
Circulation|December 31, 2011
Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantationYan Topilsky, Tal Hasin, Eugenia Raichlin, et al.
The American Journal of Cardiology|July 24, 2012
Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survivalTal Hasin, Yan Topilsky, Walter K Kremers, et al.
Transplantation|February 1, 2013
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantationYan Topilsky, Eugenia Raichlin, Tal Hasin, et al.
European Journal of Heart Failure|June 20, 2024
Physician-directed patient self-management in heart failure using left atrial pressure: Interim insights from the VECTOR-HF I and IIa studiesDavid Meerkin, Leor Perl, Tal Hasin, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
JACC. Clinical Electrophysiology|April 25, 2024
Incidence and Predictors for Recurrence of Ventricular Arrhythmia Presenting During Acute Myocarditis: A Multicenter StudyMoshe Rav-Acha, Kushal Shah, Tal Hasin, et al.
Circulation|September 6, 2022
Myocarditis After <i>BNT162b2</i> COVID-19 Third Booster Vaccine in IsraelDror Mevorach, Emilia Anis, Noa Cedar, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 24, 2017
Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One YearTal Hasin, Avishay Grupper, John J Dillon, et al.
Transplantation|January 18, 2013
Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound studyYan Topilsky, Manish J Gandhi, Tal Hasin, et al.
JAMA Network Open|March 29, 2024
Culprit Lesion Coronary Intervention Before Complete Angiography in ST-Elevation Myocardial Infarction: A Randomized Clinical TrialNir Levi, Rafael Wolff, Rami Jubeh, et al.
Journal of the American College of Cardiology|December 24, 2011
Changes in renal function after implantation of continuous-flow left ventricular assist devicesTal Hasin, Yan Topilsky, John A Schirger, et al.
Circulation|December 31, 2011
Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantationYan Topilsky, Tal Hasin, Eugenia Raichlin, et al.
The American Journal of Cardiology|July 24, 2012
Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survivalTal Hasin, Yan Topilsky, Walter K Kremers, et al.
Transplantation|February 1, 2013
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantationYan Topilsky, Eugenia Raichlin, Tal Hasin, et al.
European Journal of Heart Failure|June 20, 2024
Physician-directed patient self-management in heart failure using left atrial pressure: Interim insights from the VECTOR-HF I and IIa studiesDavid Meerkin, Leor Perl, Tal Hasin, et al.
Pageof 10